A taxonomy for disease management - A scientific statement from the American Heart Association Disease Management Taxonomy Writing Group

被引:201
|
作者
Krumholz, Harlan M.
Currie, Peter M.
Riegel, Barbara
Phillips, Christopher O.
Peterson, Eric D.
Smith, Renee
Yancy, Clyde W.
Faxon, David P.
机构
关键词
AHA Scientific Statements; disease management; chronic disease; delivery of health care; classification; heart failure;
D O I
10.1161/CIRCULATIONAHA.106.177322
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Disease management has shown great promise as a means of reorganizing chronic care and optimizing patient outcomes. Nevertheless, disease management programs are widely heterogeneous and lack a shared definition of disease management, which limits our ability to compare and evaluate different programs. To address this problem, the American Heart Association's Disease Management Taxonomy Writing Group developed a system of classification that can be used both to categorize and compare disease management programs and to inform efforts to identify specific factors associated with effectiveness. Methods-The AHA Writing Group began with a conceptual model of disease management and its components and subsequently validated this model over a wide range of disease management programs. A systematic MEDLINE search was performed on the terms heart failure, diabetes, and depression, together with disease management, case management, and care management. The search encompassed articles published in English between 1987 and 2005. We then selected studies that incorporated (1) interventions designed to improve outcomes and/or reduce medical resource utilization in patients with heart failure, diabetes, or depression and (2) clearly defined protocols with at least 2 prespecified components traditionally associated with disease management. We analyzed the study protocols and used qualitative research methods to develop a disease management taxonomy with our conceptual model as the organizing framework. Results-The final taxonomy includes the following 8 domains: (1) Patient population is characterized by risk status, demographic profile, and level of comorbidity. (2) Intervention recipient describes the primary targets of disease management intervention and includes patients and caregivers, physicians and allied healthcare providers, and healthcare delivery systems. (3) Intervention content delineates individual components, such as patient education, medication management, peer support, or some form of postacute care, that are included in disease management. (4) Delivery personnel describes the network of healthcare providers involved in the delivery of disease management interventions, including nurses, case managers, physicians, pharmacists, case workers, dietitians, physical therapists, psychologists, and information systems specialists. (5) Method of communication identifies a broad range of disease management delivery systems that may include in-person visitation, audiovisual information packets, and some form of electronic or telecommunication technology. (6) Intensity and complexity distinguish between the frequency and duration of exposure, as well as the mix of program components, with respect to the target for disease management. (7) Environment defines the context in which disease management interventions are typically delivered and includes inpatient or hospital-affiliated outpatient programs, community or home-based programs, or some combination of these factors. (8) Clinical outcomes include traditional, frequently assessed primary and secondary outcomes, as well as patient-centered measures, such as adherence to medication, self-management, and caregiver burden. Conclusions-This statement presents a taxonomy for disease management that describes critical program attributes and allows for comparisons across interventions. Routine application of the taxonomy may facilitate better comparisons of structure, process, and outcome measures across a range of disease management programs and should promote uniformity in the design and conduct of studies that seek to validate disease management strategies.
引用
收藏
页码:1432 / 1445
页数:14
相关论文
共 50 条
  • [21] Interstage Home Monitoring for Infants With Single Ventricle Heart Disease: Education and Management: A Scientific Statement From the American Heart Association
    Rudd, Nancy A.
    Ghanayem, Nancy S.
    Hill, Garick D.
    Lambert, Linda M.
    Mussatto, Kathleen A.
    Nieves, Jo Ann
    Robinson, Sarah
    Shirali, Girish
    Steltzer, Michelle M.
    Uzark, Karen
    Pike, Nancy A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (16):
  • [22] Triglycerides and Cardiovascular Disease A Scientific Statement From the American Heart Association
    Miller, Michael
    Stone, Neil J.
    Ballantyne, Christie
    Bittner, Vera
    Criqui, Michael H.
    Ginsberg, Henry N.
    Goldberg, Anne Carol
    Howard, William James
    Jacobson, Marc S.
    Kris-Etherton, Penny M.
    Lennie, Terry A.
    Levi, Moshe
    Mazzone, Theodore
    Pennathur, Subramanian
    CIRCULATION, 2011, 123 (20) : 2292 - 2333
  • [23] The role of endomyocardial biopsy in the management of cardiovascular disease - A scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology
    Cooper, Leslie T.
    Baughman, Kenneth L.
    Feldman, Arthur M.
    Frustaci, Andrea
    Jessup, Mariell
    Kuhl, Uwe
    Levine, Glenn N.
    Narula, Jagat
    Starling, Randall C.
    Towbin, Jeffrey
    Virmani, Renu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (19) : 1914 - 1931
  • [24] Surgical Management of Descending Thoracic Aortic Disease: Open and Endovascular Approaches A Scientific Statement From the American Heart Association
    Coady, Michael A.
    Ikonomidis, John S.
    Cheung, Albert T.
    Matsumoto, Alan H.
    Dake, Michael D.
    Chaikof, Elliot L.
    Cambria, Richard P.
    Mora-Mangano, Christina T.
    Sundt, Thoralf M.
    Sellke, Frank W.
    CIRCULATION, 2010, 121 (25) : 2780 - 2804
  • [25] Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure A Scientific Statement From the American Heart Association
    Chow, Sheryl L.
    Maisel, Alan S.
    Anand, Inder
    Bozkurt, Biykem
    de Boer, Rudolf A.
    Felker, G. Michael
    Fonarow, Gregg C.
    Greenberg, Barry
    Januzzi, James L., Jr.
    Kiernan, Michael S.
    Liu, Peter P.
    Wang, Thomas J.
    Yancy, Clyde W.
    Zile, Michael R.
    CIRCULATION, 2017, 135 (22) : E1054 - E1091
  • [26] Diagnosis and Management of Myocarditis in Children A Scientific Statement From the American Heart Association
    Law, Yuk M.
    Lal, Ashwin K.
    Chen, Sharon
    Cihakova, Daniela
    Cooper, Leslie T., Jr.
    Deshpande, Shriprasad
    Godown, Justin
    Grosse-Wortmann, Lars
    Robinson, Joshua D.
    Towbin, Jeffrey A.
    CIRCULATION, 2021, 144 (06) : E123 - E135
  • [27] Cardiovascular Management of Aortopathy in Children: A Scientific Statement From the American Heart Association
    Morris, Shaine A.
    Flyer, Jonathan N.
    Yetman, Anji T.
    Quezada, Emilio
    Cappella, Elizabeth S.
    Dietz, Harry C.
    Milewicz, Dianna M.
    Ouzounian, Maral
    Rigelsky, Christina M.
    Tierney, Seda
    Lacro, Ronald V.
    CIRCULATION, 2024, 150 (11) : e228 - e254
  • [28] Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association
    Cheng, Richard K.
    Kittleson, Michelle M.
    Beavers, Craig J.
    Birnie, David H.
    Blankstein, Ron
    Bravo, Paco E.
    Gilotra, Nisha A.
    Judson, Marc A.
    Patton, Kristen K.
    Rose-Bovino, Leonie
    CIRCULATION, 2024, 149 (21) : e1197 - e1216
  • [29] Pulmonary Hypertension in Congenital Heart Disease: A Scientific Statement From the American Heart Association
    Jone, Pei-Ni
    Ivy, D. Dunbar
    Hauck, Amanda
    Karamlou, Tara
    Truong, Uyen
    Coleman, Ryan D.
    Sandoval, Juan Pablo
    del Cerro Marin, Maria Jesus
    Eghtesady, Pirooz
    Tillman, Kathryn
    Krishnan, Usha S.
    CIRCULATION-HEART FAILURE, 2023, 16 (07)
  • [30] Management of Hypertension in Patients With Ventricular Assist Devices: A Scientific Statement From the American Heart Association
    Eisen, Howard J.
    Flack, John M.
    Atluri, Pavan
    Bansal, Neha
    Breathett, Khadijah
    Brown, Angela L.
    Hankins, Shelley R.
    Khazanie, Prateeti
    Masri, Carolina
    Pirlamarla, Preethi
    Rowe, Theresa
    CIRCULATION-HEART FAILURE, 2022, 15 (05) : 541 - 551